Healthcare technology news, life science current events
700 followers 29 článkov/týždeň
Lundbeck’s Neuro-Rare Pipeline Lands Cornerstone Drug via $2.6B Longboard Pharma Acquisition

Lundbeck says Longboard Pharmaceuticals’ drug, bexicaserin, has potential applications in a range of rare epilepsies. Last month, the biotech began a Phase 3 clinical trial testing the drug in Dravet syndrome. The post Lundbeck’s Neuro-Rare Pipeline Lands Cornerstone Drug via $2.6B Longboard Pharma Acquisition appeared first on MedCity News.

Mon Oct 14, 2024 23:23
Suki Secures $70M To Expand AI Offerings

Suki’s $70 million Series D financing round was led by Hedosophia and included participation from Venrock, March Capital, Flare Capital, Breyer Capital and inHealth Ventures. The post Suki Secures $70M To Expand AI Offerings appeared first on MedCity News.

Mon Oct 14, 2024 19:26
Community Pharmacies Fill Critical Healthcare Gaps in Rural Areas — Here’s How We Can Empower and Support Them

We need to equip pharmacists with technology that can help them to make impactful clinical interventions in the pharmacy and reimburse them for these services, which would help to address the provider shortage. The post Community Pharmacies Fill Critical Healthcare Gaps in Rural Areas — Here’s How We Can Empower and Support Them appeared first on MedCity...

Mon Oct 14, 2024 18:26
Precision Psychiatry is Possible — Especially if We Use Evidence-based Neural Measures to Drive Better Mental Health Treatment and Outcomes

By moving beyond subjective and heterogeneous criteria and embracing objective brain function measures, the field of psychiatry can achieve greater precision and efficacy in addressing complex disorders. The post Precision Psychiatry is Possible — Especially if We Use Evidence-based Neural Measures to Drive Better Mental Health Treatment and Outcomes...

Mon Oct 14, 2024 18:26
Aiming to Outdo Rivals in Severe Asthma, Upstream Bio Upsizes IPO to $225M

Upstream Bio will use its IPO haul to continue clinical testing of verekitug, which it contends be a better treatment option for severe asthma compared to a commercialized Amgen and AstraZeneca drug. CAMP4 Therapeutics and Ceribell also priced IPOs to join the public markets. The post Aiming to Outdo Rivals in Severe Asthma, Upstream Bio Upsizes...

Sat Oct 12, 2024 01:17
Medicare Advantage Star Ratings Drop Again

For 2025, the average star rating for Medicare Advantage Prescription Drug contracts was 3.92, compared to 4.07 for 2024, 4.14 for 2023 and 4.37 for 2022. The post Medicare Advantage Star Ratings Drop Again appeared first on MedCity News.

Fri Oct 11, 2024 22:14

Vytvorte si vlastný informačný kanál

Ste pripravení to vyskúšať?
Začnite 14-dňovú skúšobnú verziu, kreditná karta sa nevyžaduje.

Založiť účet